English
|
Spanish
Supporting oncology professionals through education
Login
Register
The content on this site is intended for healthcare professionals only
Menu
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
News
Latest news
Sign up for news alerts
Submit your news
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Journal information
Journal home
Charges
Editorial board
Founding editors
Editor-in-chief
Contact us
Author information
Submit article
Author guidelines
Editorial policies
Copyright information
Why publish with us
Reviewer information
Reviewer guidelines
Memberships
Videos
Recent videos
Sign up
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Conferences
Latest conferences
Sign up for latest coverage
Submit your event
About
e
cancer
About
e
cancer
Our founders
Funding statement
Contact us
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+
-
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
Results of the new Cetuximab studies in mCRC, from ASCO 2008
Share :
2009 ASCO Annual Meeting
29 May - 2 Jun 2009
Please rate this video
The information in this video was of interest to me
The information in this video is likely to improve my clinical practice or research
I would recommend this video to my colleagues
Published:
28 Nov 2008
Views:
14168
Rating:
Save
Rate video
Professor Eric Van Cutsem
Categories:
Colorectal & gastro
Related Videos
Durvalumab, gemcitabine and cisplatin continue to show clinically meaningful...
Dr Do-Youn Oh - Seoul National University Hospital, Seoul, Korea
15 Jul 2024
Gastrointestinal Tumors
Dr Jesus Fabregas - Memorial Cancer Institute, Miami, USA
12 Jul 2024
GI Tumors Panel
Dr Samuel Kareff - University of Miami Sylvester Comprehensive Cancer Center...
12 Jul 2024
Pembrolizumab combined with xelox and bevacizumab shows higher efficacy than...
Prof David Tougeron - Poitiers University Hospital, Poitiers, France
9 Jul 2024
Paclitaxel and ramucirumab switch maintenance therapy prolongs survival in HER2...
Dr Giovanni Randon - The National Cancer Institute of Milan, Milano, Italy
9 Jul 2024
Administering systemic chemotherapy improves survival for patients with...
Dr Giacomo Bregni - Francis Crick Institute, London, England
9 Jul 2024
Immunotherapy significantly increases the number of patients free from bowel...
Dr Kai-Keen Shiu - UCL Cancer Institute, London, UK
14 Jun 2024
Nivolumab plus ipilimumab shows clinical benefit as first-line treatment for...
Prof Heinz-Josef Lenz - Keck School of Medicine of USC, Los Angeles, USA
2 Jun 2024
Avelumab combined with regorafenib shows improved outcome in solid tumours with...
Prof Antoine Italiano - Institute Bergonié, Bordeaux, France
24 Apr 2024
More from
e
cancer